CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...
The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a 1.4 million–protein PBMC dataset available in the Nomic Portal Nomic Bio (“Nomic” ...
Protein detection sensitivity has historically lagged behind nucleic acid detection by 2-3 orders of magnitude due to the lack of intrinsic signal amplification. While digital methods such as Single ...
To test the accuracy of the Octet ® assay, Fc-fusion protein was spiked into CCM and HCP matrices at known concentrations in ...
Codetta Bio introduced the Concerto platform at AACR in 2025 and initially made the technology available through a service-based Technology Access Program (TAP). Following strong customer engagement ...
Abselion has launched the His-Tagged Protein Quantification Kit for use with its Amperia™ benchtop platform. Developed with GenScript’s THE™ His Tag Monoclonal Antibodies, the kit enables rapid ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...
Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025 Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results